Blutt S, Conner M
Front Immunol. 2013; 4:402.
PMID: 24348474
PMC: 3842584.
DOI: 10.3389/fimmu.2013.00402.
Russell S, Peng K
Trends Pharmacol Sci. 2007; 28(7):326-33.
PMID: 17573126
PMC: 3125087.
DOI: 10.1016/j.tips.2007.05.005.
Gauntt C, Paque R, Trousdale M, Gudvangen R, Barr D, Lipotich G
Infect Immun. 1983; 39(2):851-64.
PMID: 6299950
PMC: 348027.
DOI: 10.1128/iai.39.2.851-864.1983.
Cho C, Feng K, McCarthy V, LENAHAN M
Infect Immun. 1982; 37(2):720-7.
PMID: 6288570
PMC: 347590.
DOI: 10.1128/iai.37.2.720-727.1982.
Woodruff J
Am J Pathol. 1980; 101(2):425-84.
PMID: 6254364
PMC: 1903609.
The effect of immunosuppression with cyclophosphamide on an experimental porcine enterovirus infection in piglets.
Derbyshire J
Can J Comp Med. 1983; 47(2):235-7.
PMID: 6224548
PMC: 1235923.
The immune response to virus infections.
Onions D
Vet Immunol Immunopathol. 1983; 4(1-2):237-77.
PMID: 6191431
PMC: 7119848.
DOI: 10.1016/0165-2427(83)90059-4.
Cell mediated responses in a porcine enterovirus infection in piglets.
Brundage L, Derbyshire J, Wilkie B
Can J Comp Med. 1980; 44(1):61-9.
PMID: 6156747
PMC: 1320035.
Interactions of T-and B-lymphocytes and macrophages in recovery from virus infections.
Allison A
Proc R Soc Med. 1973; 66(12):1151-4.
PMID: 4599617
PMC: 1645299.
Effect of immunosuppression on arthritis in mice induced by Mycoplasma pulmonis.
Taylor G, Taylor-Robinson D, Slavin G
Ann Rheum Dis. 1974; 33(4):376-84.
PMID: 4547195
PMC: 1006275.
DOI: 10.1136/ard.33.4.376.
Cardiovascular diseases due to viruses.
KAWANA R
Heart Vessels Suppl. 1985; 1:91-6.
PMID: 3843596
DOI: 10.1007/BF02072370.
Multi-system coxsackievirus B-6 infection with findings suggestive of diabetes mellitus.
Nigro G, Pacella M, PATANE E, Midulla M
Eur J Pediatr. 1986; 145(6):557-9.
PMID: 3028808
DOI: 10.1007/BF02429065.
Cardiomyopathy and myocarditis--a review of new aspects in research in West Germany.
Maisch B, Izumi T
Heart Vessels Suppl. 1985; 1:8-13.
PMID: 2956241
DOI: 10.1007/BF02072351.
Immunomodulating therapy in experimental myocarditis.
Matsumori A, Kawai C
Springer Semin Immunopathol. 1989; 11(1):77-88.
PMID: 2665156
DOI: 10.1007/BF00197087.
Coxsackievirus infection as a trigger of cardiac autoimmunity.
Wolfgram L, Rose N
Immunol Res. 1989; 8(1):61-80.
PMID: 2647869
DOI: 10.1007/BF02918555.
Antimyocarditic activity of the guanine derivative BIOLF-70 in a coxsackievirus B3 murine model.
Gauntt C, Arizpe H, Kung J, Ogilvie K, Cheriyan U
Antimicrob Agents Chemother. 1985; 27(2):184-91.
PMID: 2580480
PMC: 176235.
DOI: 10.1128/AAC.27.2.184.
Antigen-specific suppressor T cells prevent cardiac injury in Balb/c mice infected with a nonmyocarditic variant of coxsackievirus group B, type 3.
Estrin M, Smith C, Huber S
Am J Pathol. 1986; 125(3):578-84.
PMID: 2432792
PMC: 1888464.
An attenuated variant of Coxsackievirus B3 preferentially induces immunoregulatory T cells in vivo.
Loudon R, Moraska A, Huber S, Schwimmbeck P, Schultheiss P
J Virol. 1991; 65(11):5813-9.
PMID: 1656071
PMC: 250243.
DOI: 10.1128/JVI.65.11.5813-5819.1991.
Androstenediol regulates systemic resistance against lethal infections in mice.
Loria R, Padgett D
Arch Virol. 1992; 127(1-4):103-15.
PMID: 1456887
DOI: 10.1007/BF01309578.
Immunization of mice against Coxsackievirus B3 and prevention of foetal growth retardation.
Lansdown A, Brown J
Br J Exp Pathol. 1976; 57(5):521-4.
PMID: 999788
PMC: 2041221.
